Cowan Elvia
Reporting owner on Forms 3, 4 and 5, CIK 1960048.
Cowan Elvia reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-07.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| PCVX · Vaxcyte, Inc.CIK 1649094 | officer (SVP, Finance & CAO) | 1 | 2026-10-07 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| PCVX · Vaxcyte, Inc.Common Stock | 2026-10-05 | M exercised | +19,000 | $25.92 | 46,860 | Form 4 |
| PCVX · Vaxcyte, Inc.Common Stock | 2026-10-05 | S sold | -19,000 | $86.74 | 27,860 | Form 4 |
| PCVX · Vaxcyte, Inc.Stock Option (right to buy), derivative | 2026-10-05 | M exercised | -19,000 | $0 | 74,068 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001960048-26-000013 | Vaxcyte, Inc. | 2026-10-07 |